Press Releases on June 27, 2019 - EIN Presswire - Press Release Distribution Service

Published on June 27, 2019 - 20:10 GMT

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In RCI ...

NEW YORK, June 27, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in RCI Hospitality Holdings, Inc. ("RCI" or the "Company")(NASDAQ:RICK) of the July 22, 2019 deadline to …

Distribution channels: Consumer Goods, Law ...

Published on June 27, 2019 - 20:10 GMT

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Aerohive Networks, Inc. (NYSE: HIVE) on Behalf of Aerohive ...

NEW YORK, June 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Aerohive Networks, Inc. (NYSE: HIVE) on behalf of Aerohive shareholders concerning the proposed merger with …

Distribution channels: Consumer Goods, Law ...

Published on June 27, 2019 - 20:10 GMT

Chiasma Set to Join Russell 3000® Index

WALTHAM, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced that the company has been selected …

Distribution channels: ...

Published on June 27, 2019 - 20:10 GMT

CrowdStrike Announces Date of Fiscal First Quarter 2020 Results Conference Call

SUNNYVALE, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- CrowdStrike Holdings, Inc. (Nasdaq: CRWD), today announced that it will release financial results for its fiscal first quarter 2020 ended April 30, 2019 after the U.S. market close on Thursday, July 18, …

Distribution channels: Conferences & Trade Fairs, Technology ...

Published on June 27, 2019 - 20:10 GMT

Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled IL-12 with Libtayo® (cemiplimab-rwlc) to ...

BOSTON, June 27, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced the initiation of a phase 2 clinical trial evaluating Controlled IL-12 (Ad-RTS-hIL-12 plus veledimex, Ad+V), in combination with …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 27, 2019 - 20:08 GMT

b-2Cool’s U.S. Strategy Extinguishes Fires to Reshape Native Type II Collagen Market

ANN ARBOR, Mich., June 27, 2019 (GLOBE NEWSWIRE) -- Bioiberica’s entry into the U.S. market for its native (undenatured) type II collagen, b-2Cool, through exclusive distributer Berg Nutrition, was initially met with attack; a story that parallels the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 27, 2019 - 20:07 GMT

40 National and State Non-Profits to OMB: Don’t Take Basic Benefits Away from Millions of Americans

Washington, DC, June 27, 2019 (GLOBE NEWSWIRE) -- Forty non-profit organizations, representing patients, religious groups, retirees and civil rights advocates, united in protest of a recent proposal by the Trump Administration that could take away health …

Distribution channels: